Breast Cancer Trial, Not Yet Recruiting NCT06865755 Sponsor: San Diego State University Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT06865755
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who speak and read English
  • People between the ages of 21 and 70 years old
  • People who have been diagnosed with stage 0 to 3 breast cancer within the past 5 years
  • People who have finished all surgery, radiation, and chemotherapy (ongoing hormone-blocking medication is an exception)
  • People who have been prescribed hormone-blocking medication (endocrine therapy) for their breast cancer
  • People who do not have a physical condition that would stop them from using the study's mobile monitoring (MM) system
  • People who are able to give informed consent to participate
  • People who are willing and able to use the study's mobile monitoring (MM) system for 6 months
  • People who own an iPhone or Android smartphone

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have a physical impairment that would prevent them from using the study's mobile monitoring (MM) system

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 619-594-1919

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
San Diego State University
Registry
ClinicalTrials.gov
Start date
1 July 2026
Est. completion
1 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Wisepill MEMS Sensor data collection; Intervention component - Introduction; Intervention component - Instructions; Intervention component - calendar; Intervention component - resources; Intervention component - relaxation audio files; Intervention component - social support; Intervention component - tamoxifen; Intervention component - aromatase inhibitors; Intervention component - routine; Intervention component - reminders; Intervention component - joint pain; Intervention component - hot flashes; Intervention component - pacing; Intervention component - relaxation; Intervention component -...

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov